Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Graefes Arch Clin Exp Ophthalmol. 2017 Dec 8;256(2):299–306. doi: 10.1007/s00417-017-3858-8

Fig. 1.

Fig. 1

Panels 1a, 1b, and 1c show the change in ETDRS VA letters from baseline over time for subjects 1, 2, and 3, respectively (five letters = 1 line = 0.1 logMAR). Panels 1d, 1e, and 1f show the changes in the qCSF test results from baseline over time for subjects 1, 2, and 3, respectively. The asterisks along the x-axis indicate the assessment that occurred four to 7 weeks after completion of each TES treatment course of six weekly sessions. The bar along the top of each figure panel indicates the periods during which TES was administered (gray shaded areas) and when no TES was administered (white areas)